Aethlon Medical Files Cancer Treatment Patent (RedNova)
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that it has filed a international patent application under the Patent Cooperation Treaty (PCT) entitled, Extracorporeal Removal of Microvesicular Particles.

New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief (Business Wire via Yahoo! Finance)
FAIR LAWN, N.J.----Vyteris Holdings , Inc. , today announced results from a new phase IV "Open Label" clinical study demonstrating that LidoSite, the first FDA approved active patch for dermal analgesia, provided better pain relief to more than 73 percent of patients receiving injections of hyaluronic acid during treatment for osteoarthritis than usual topical analgesics.

Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets (PR Newswire via Yahoo! Finance)
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Otsuka Pharmaceutical Co., Ltd in connection with its ABILIFY tablets, 2mg, 5mg, 10mg, 15mg, 20mg & 30mg.